NDC 67457-592 – Arixtra

Fondaparinux Sodium 2.5 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC67457-592

Product details

Brand name
Arixtra
Generic name
Fondaparinux sodium
Labeler
Mylan Institutional LLC
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA021345
Marketed since
May 19, 2014
Listing expires
December 31, 2026
Pharmacologic class
Factor Xa Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Arixtra →

Package NDC codes (1)

Package NDCDescriptionSince
67457-592-1010 SYRINGE, GLASS in 1 CARTON (67457-592-10) / .5 mL in 1 SYRINGE, GLASS (67457-592-00)May 19, 2014

Other Arixtra products